Symmetry Investments LP Acquires Shares of 2,171 Humana Inc. (NYSE:HUM)

Symmetry Investments LP bought a new stake in Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,171 shares of the insurance provider’s stock, valued at approximately $551,000.

Other institutional investors have also recently made changes to their positions in the company. FPC Investment Advisory Inc. bought a new stake in Humana in the 4th quarter valued at about $27,000. Centricity Wealth Management LLC bought a new position in Humana during the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA increased its stake in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new stake in shares of Humana in the fourth quarter valued at approximately $33,000. Finally, Transce3nd LLC purchased a new stake in shares of Humana during the 4th quarter valued at approximately $38,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $258.87 on Wednesday. The company has a market capitalization of $31.24 billion, a price-to-earnings ratio of 26.02, a PEG ratio of 2.05 and a beta of 0.62. The business has a 50 day moving average of $265.74 and a 200 day moving average of $270.19. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Wall Street Analyst Weigh In

HUM has been the topic of a number of analyst reports. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Barclays raised their target price on Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research note on Friday, April 11th. StockNews.com upgraded Humana from a “hold” rating to a “buy” rating in a research report on Monday, April 7th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Seventeen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.